Taurine is a well-known free amino acid that has gained prominence in recent years despite its little or no role in protein formation. Few studies on the ergogenic effect of taurine exist with inconsistent results. This study aimed to reach a consensus about whether taurine supplementation is effective on aerobic and anaerobic performance outputs. Google Scholar, Pubmed databases, clinical trial websites, and grey literature were reviewed until November 2021. Mean differences were pooled using random or fixed-effects models according to the heterogeneity degree of related outcomes. Although 17 studies were detected for the meta-analysis between 2001-2021, 15 studies were grouped.Only randomized controlled trials were considered. Taurine supplementation had a significant effect on vertical (MD 5 3.60; 95% CI [2.32 to 4.89], p , 0.00001) and countermovement (MD 5 8.50; 95% CI [4.78 to 12.22], p , 0.00001) jump performance when compared to a placebo group. Taurine supplementation had no significant effect on V Ȯ2 max level and rate of perceived exertion (respectively, MD 5 -0.54 mL/kg/min; 95% CI [-6.84 to 5.75], p 5 0.87; MD 5 -0.24; 95% CI [-0.74 to 0.27], p 5 0.35) when compared to a placebo group. Taurine improves potentially jumping performance and time to exhaustion.

In previous studies, the effect of single or combined intake of caffeine (CAF) and taurine (TAU) on exercise performance was investigated. However, the potential synergistic effect on physical and cognitive performance after fatigue induced by anaerobic exercise is unknown. The effects of single and combination CAF and TAU supplementation on the Wingate test in elite male boxers and to evaluate balance, agility and cognitive performance after fatigue are being investigated for the first time in this study. Twenty elite male boxers 22.14 ± 1.42 years old were divided into four groups in this double-blind, randomized crossover study: CAF (6 mg/kg of caffeine), TAU (3 g single dose of taurine), CAF*TAU (co-ingestion of 3 g single dose of taurine and 6 mg/kg of caffeine) and PLA (300 mg maltodextrin). The findings are as follows: co-ingestion of CAF*TAU, improved peak (W/kg), average (W), minimum (W) power, time to reach (s), and RPE performances compared to the PLA group significantly (p < 0.05). Similarly, it was determined that a single dose of TAU, created a significant difference (p < 0.05) in peak power (W/kg), and average and minimum power (W) values compared to the CAF group. According to the balance and agility tests performed after the Wingate test, co-ingestion of CAF*TAU revealed a significant difference (p < 0.05) compared to the PLA group. In terms of cognitive performance, co-ingestion of CAF*TAU significantly improved the neutral reaction time (ms) compared to the TAU, CAF and PLA groups. As a result, elite male boxers performed better in terms of agility, balance and cognitive function when they consumed a combination of 6 mg/kg CAF and 3 g TAU. It has been determined that the combined use of these supplements is more effective than their single use.

No abstract

No abstract

Background: Taurine is a well-known free amino acid that has gained prominence in recent years despite its little or no role in protein formation. Few studies on the ergogenic effect of taurine exist with inconsistent results. The question on whether performance markers show the benefit from the taurine remains open. This study aimed to reach a consensus about whether taurine supplementation is effective on aerobic (time to exhaustion, VO2max, and rating of perceived exertion) and anaerobic (jumping, blood lactate level) performance outputs. Methods: Google Scholar, Pubmed databases, clinical trial websites, and grey literature were reviewed until November 2021. Mean differences (MDs) were pooled using random or fixed-effects models according to the heterogeneity degree of related outcomes. Although 17 studies were detected for the meta-analysis between 2001-2021, 15 studies were grouped. Only randomized controlled trials (single or double-blind) were considered. Results: Taurine supplementation had a significant effect on vertical (MD =3.60; 95% CI 2.32 to 4.89, p <0.00001) and countermovement (MD = 8.50; 95% CI 4.78 to 12.22, p <0.00001) jump performance when compared to a placebo group. Taurine supplementation had no significant effect on VO2max level and rate of perceived exertion (respectively, MD = −0.54 ml/kg/min; 95% CI −6.84 to 5.75, p=0.87; MD = −0.24; 95% CI −0.74 to 0.27, p=0.35) when compared to a placebo group. Conclusion: Taurine improves potentially jumping performance and time to exhaustion.